Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add filters








Language
Year range
1.
Indian J Dermatol Venereol Leprol ; 2022 Apr; 88(2): 270-273
Article | IMSEAR | ID: sea-222949
2.
Indian J Dermatol Venereol Leprol ; 2019 Jan; 85(1): 125-128
Article | IMSEAR | ID: sea-192449
3.
Indian J Dermatol Venereol Leprol ; 2018 Jan; 84(1): 114-116
Article | IMSEAR | ID: sea-192336
4.
Indian J Dermatol Venereol Leprol ; 2010 Sept-Oct; 76(5): 591
Article in English | IMSEAR | ID: sea-140711

ABSTRACT

Background: Topical corticosteroids (CSs) are the mainstay of therapy in various steroid responsive dermatoses. Newer CSs are more efficacious and safer than the older ones. There is no published data on the efficacy and safety of a new steroid hydrocortisone aceponate in the Indian population. Aim: To evaluate the efficacy and safety of hydrocortisone aceponate (0.127%) lipophilic cream in the treatment of steroid responsive dermatoses in Indian patients. Methods: Four hundred and fifteen patients with clinically diagnosed steroid responsive dermatoses enrolled in this study. They were advised to apply hydrocortisone aceponate (0.127%) lipophilic cream as a thin film to all the affected areas twice daily. Cleansing was done prior to the application with either soap-free cleanser or soap (that would not affect the study result). Use of oral antihistamines and/or antibiotics was permissible. However, other oral/topical steroid use was not permitted during the study. Patients were evaluated at day 0 and at day 21. Data were recorded regarding clinical improvement and side-effects, if any. They were then analyzed to determine the efficacy and safety of the cream. Results: Physician's global evaluation of therapy showed that lesions were cleared in 82 (22.10%), excellent result in 200 (53.91%), good result in 72 (19.41%), fair response in 15 (4.04%) and no change in 2 (0.54%) patients. There was no history of exacerbation in any patient. Conclusion: The study showed that hydrocortisone aceponate (0.127%) lipophilic cream is an effective therapeutic agent with a very good safety profile in various steroid responsive dermatoses in the Indian patient population.

5.
Indian J Dermatol Venereol Leprol ; 2005 Nov-Dec; 71(6): 421-2
Article in English | IMSEAR | ID: sea-52163

ABSTRACT

Blaschko's lines form a pattern, which many diseases are found to follow, but linear scleroderma following Blaschko's lines is a controversial entity rarely reported in the literature. A 24-year-old man presented with multiple linear, atrophic, hyperpigmented lesions punctuated by areas of depigmentations on the left half of the trunk distributed on the anterior, lateral and posterior aspects. The lesions were distributed in a typical S-shaped line. Antinuclear antibody and antihistone antibody tests were negative. Histopathological examination of the skin from the affected area showed features suggestive of scleroderma. Here, we present a case of linear scleroderma following Blaschko's lines in a male patient--an entity reported only three times so far.


Subject(s)
Adult , Humans , Male , Scleroderma, Localized/pathology , Skin/pathology
6.
Indian J Dermatol Venereol Leprol ; 2005 Mar-Apr; 71(2): 130-1
Article in English | IMSEAR | ID: sea-52484
7.
Indian J Dermatol Venereol Leprol ; 2004 Nov-Dec; 70(6): 364-6
Article in English | IMSEAR | ID: sea-52133

ABSTRACT

Porokeratosis is a genodermatosis characterized by abnormal epidermal keratinization with the histological feature of cornoid lamella. There are many clinical variants, but two or more of these variants rarely occur in a single patient. This variation in clinical presentation may be due to the different phenotypic expression of a common genetic abnormality or may be the consequence of abnormalities in closely linked genetic loci or genes. Here we report about a child who showed simultaneous occurrence of disseminated, linear and hypertrophic verrucous lesions of porokeratosis. He also had genital lesions, reported uncommonly in the medical literature.

SELECTION OF CITATIONS
SEARCH DETAIL